Amifostine pretreatment for protection against topotecan-induced hematologic toxicity: results of a multicenter phase III trial in patients with advanced gynecologic malignancies

Author: Gold M.A.   Walker J.L.   Berek J.S.   Hallum A.V.   Garcia D.J.   Alberts D.S.  

Publisher: Elsevier

ISSN: 0090-8258

Source: Gynecologic Oncology, Vol.90, Iss.2, 2003-08, pp. : 325-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content